CHAMPION INDS W VA Stock Quote

$0.38 arrow  Change: 0.38 %Chge: 0.00% Vol: 264
End Of Day Prices
High: 0.38 | Low: 0.38 | Open: 0.38 | Close: 0.38
52 Wk High: 0.4977 | 52 Wk Low: 0.38 | Todays Pivot: 0.38
Sector: add stock to watch list

CHMP Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Champion Inds W Va

Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate® romiplostim In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura

The positive CHMP opinion was based on five studies evaluating the safety and efficacy of Nplate in children with ITP, including four completed studies (a Phase 3, a Phase 1/2 placebo-controlled study, and two long-term safety and efficacy studies) and one ...


Takeda Pharmaceutical : Receives Positive CHMP Opinion for ADCETRIS for CD30-Positive Cutaneous T-Cell Lymphoma

Cambridge, Mass. and Osaka, Japan - Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the extension of the ...


BRIEF-Shire says CHMP recommends EU marketing authorization for ADYNOVI [Antihemophilic Factor (Recombinant), PEGylated]

Nov 13 (Reuters) - SHIRE PLC: * CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR ADYNOVI [antihemophilic factor (recombinant), pegylated] FOR ADULTS AND ADOLESCENTS WITH HEMOPHILIA A Source text for Eikon: Further company coverage: (Bangalore.newsroom@ ...


Europe’s CHMP Gives Its Blessing to Vertex’s Orkambi as CF Therapy for Younger Children

The European Union’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for Orkambi (ivacaftor/lumacaftor) as a therapy for cystic fibrosis (CF) in children. The ruling is specifically for pediatric patients ...


CHMP recommends EU marketing authorization for ADYNOVI® for adults and adolescents with Hemophilia A

CHMP recommends EU marketing authorization for ADYNOVI ® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A If approved, ADYNOVI, built on ADVATE ® [Antihemophilic Factor (Recombinant)], would offer twice-weekly ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Champion Inds W Va quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for CHMP to choose from. Visit here to build your stock quote widget »